Amdocs executive sells 464 shares in open market
Amdocs Ltd executive Matthew E. Smith reported an open-market sale of company stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Amdocs Ltd executive Matthew E. Smith reported an open-market sale of company stock. On this Form 4, he sold 464 Ordinary Shares of Amdocs on May 29, 2026 at an average price of $62.51 per share, for roughly $29,000 in proceeds.
After the transaction, Smith directly holds 1,550 Ordinary Shares of Amdocs. The filing reflects a routine insider sale rather than a change in compensation or option exercise, and no derivative securities are reported as remaining positions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares | 464 | $62.51 | $29K |
Key Figures
Key Terms
open-market sale financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Amdocs (DOX) report for Matthew E. Smith?
Was the Amdocs (DOX) insider transaction a buy or a sell?
Did the Amdocs (DOX) Form 4 include any option exercises or derivative securities?
AI-generated analysis. How Rhea-AI works. Not financial advice.